SCHEMBL28847349

SCHEMBL28847349

CN1CCN(Cc2c(C(N)=O)cccc2C(F)(F)F)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
POLB P06746 2/20 0.49
ALDH1A1 P00352 2/20 0.49
PARP1 P09874 4/20 0.48
PARP2 Q9UGN5 1/20 0.48
PARP3 Q9Y6F1 1/20 0.48
KIT P10721 2/20 0.47
TSHR P16473 1/20 0.46
NR1H2 P55055 1/20 0.46
ATM Q13315 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
GAA P10253 1/20 0.43
SCD O00767 1/20 0.42
CHEK1 O14757 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
SCN9A Q15858 1/20 0.41
GNRHR P30968 1/20 0.41
HRH4 Q9H3N8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4742353 0.90 PARP1 (0.44) KDM4EPOLBALDH1A1PARP1PARP2
SCHEMBL28262408 0.88 KDM4E (0.50) KDM4EPOLBALDH1A1KITTSHR
SCHEMBL28321312 0.88 KDM4E (0.46) KDM4EPOLBALDH1A1PARP1PARP2
SCHEMBL20357333 0.85 CHRM3 (0.51) KDM4EALDH1A1PARP1PARP2ATM
SCHEMBL2679792 0.85 PARP1 (0.48) KDM4EALDH1A1PARP1PARP2PARP3
SCHEMBL27734230 0.81 NR1H2 (0.54) KDM4EPOLBALDH1A1KITTSHR
SCHEMBL17857128 0.80 ALDH1A1 (0.55) KDM4EPOLBALDH1A1KITTSHR
SCHEMBL31053450 0.78 PARP1 (0.40) KDM4EPOLBALDH1A1PARP1PARP2
SCHEMBL29286662 0.76 CD38 (0.46) PARP1GAA
SCHEMBL2925004 0.75 PARP1 (0.48) KDM4EPOLBALDH1A1PARP1PARP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110291081-A BENZIMIDAZOLE COMPOUNDS AS C-KIT INHIBITORS 阿瑞雅德制药公司 2019-09-27 CN claimed
CN-109111395-B Novel BCR-ABL kinase inhibitor 中国科学院合肥物质科学研究院 2022-08-30 CN disclosed
CN-111072636-B Synthesis method of flumatinib 江苏豪森药业集团有限公司 2022-08-23 CN disclosed
CN-111072636-A Synthesis method of flumatinib 江苏豪森药业集团有限公司 2020-04-28 CN disclosed
CN-109111395-A Novel BCR-ABL kinase inhibitor 中国科学院合肥物质科学研究院 2019-01-01 CN disclosed